ArticleWorld journal of microbiology & biotechnology2024

Oral administration of recombinant outer membrane protein A-based nanovaccine affords protection against Aeromonas hydrophila in zebrafish.

Mave Harshitha et al.PubMed ↗Publisher ↗

No numbers read from the abstract.